vs
Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and GERON CORP (GERN). Click either name above to swap in a different company.
Armour Residential REIT, Inc. is the larger business by last-quarter revenue ($50.4M vs $47.2M, roughly 1.1× GERON CORP). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs -39.0%, a 459.3% gap on every dollar of revenue. On growth, Armour Residential REIT, Inc. posted the faster year-over-year revenue change (297.9% vs 67.1%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 108.0%).
Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
ARR vs GERN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $50.4M | $47.2M |
| Net Profit | $211.7M | $-18.4M |
| Gross Margin | — | — |
| Operating Margin | — | -29.4% |
| Net Margin | 420.2% | -39.0% |
| Revenue YoY | 297.9% | 67.1% |
| Net Profit YoY | 555.9% | 30.3% |
| EPS (diluted) | $2.43 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.4M | — | ||
| Q3 25 | $38.5M | $47.2M | ||
| Q2 25 | $33.1M | $49.0M | ||
| Q1 25 | $36.3M | $39.6M | ||
| Q4 24 | $12.7M | — | ||
| Q3 24 | — | $28.3M | ||
| Q2 24 | $7.0M | $882.0K | ||
| Q1 24 | — | $304.0K |
| Q4 25 | $211.7M | — | ||
| Q3 25 | $159.3M | $-18.4M | ||
| Q2 25 | $-75.6M | $-16.4M | ||
| Q1 25 | $27.3M | $-19.8M | ||
| Q4 24 | $-46.4M | — | ||
| Q3 24 | — | $-26.4M | ||
| Q2 24 | $-48.4M | $-67.4M | ||
| Q1 24 | — | $-55.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | -29.4% | ||
| Q2 25 | — | -25.4% | ||
| Q1 25 | — | -42.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -99.8% | ||
| Q2 24 | — | -7860.9% | ||
| Q1 24 | — | -18465.1% |
| Q4 25 | 420.2% | — | ||
| Q3 25 | 413.5% | -39.0% | ||
| Q2 25 | -228.4% | -33.4% | ||
| Q1 25 | 75.2% | -50.1% | ||
| Q4 24 | -366.8% | — | ||
| Q3 24 | — | -93.5% | ||
| Q2 24 | -693.8% | -7639.8% | ||
| Q1 24 | — | -18220.4% |
| Q4 25 | $2.43 | — | ||
| Q3 25 | $1.49 | $-0.03 | ||
| Q2 25 | $-0.94 | $-0.02 | ||
| Q1 25 | $0.32 | $-0.03 | ||
| Q4 24 | $-0.91 | — | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | $-1.05 | $-0.10 | ||
| Q1 24 | — | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.3M | $78.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.3B | $248.7M |
| Total Assets | $21.0B | $567.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.3M | — | ||
| Q3 25 | $44.2M | $78.1M | ||
| Q2 25 | $141.2M | $77.7M | ||
| Q1 25 | $49.1M | $83.7M | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | — | $60.3M | ||
| Q2 24 | $126.6M | $116.9M | ||
| Q1 24 | — | $189.8M |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.1B | $248.7M | ||
| Q2 25 | $1.7B | $259.5M | ||
| Q1 25 | $1.7B | $268.2M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | — | $292.3M | ||
| Q2 24 | $1.2B | $306.7M | ||
| Q1 24 | — | $344.9M |
| Q4 25 | $21.0B | — | ||
| Q3 25 | $19.4B | $567.4M | ||
| Q2 25 | $16.2B | $555.2M | ||
| Q1 25 | $15.5B | $562.5M | ||
| Q4 24 | $13.5B | — | ||
| Q3 24 | — | $444.9M | ||
| Q2 24 | $10.1B | $449.4M | ||
| Q1 24 | — | $482.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $124.2M | $-13.6M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.2M | — | ||
| Q3 25 | $-37.8M | $-13.6M | ||
| Q2 25 | $25.0M | $-27.4M | ||
| Q1 25 | $101.5M | $-48.0M | ||
| Q4 24 | $261.5M | — | ||
| Q3 24 | — | $-58.9M | ||
| Q2 24 | $27.1M | $-53.5M | ||
| Q1 24 | — | $-62.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-53.7M | ||
| Q1 24 | — | $-62.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6086.6% | ||
| Q1 24 | — | -20680.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 23.4% | ||
| Q1 24 | — | 202.3% |
| Q4 25 | 0.59× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.